Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.38 |
| ▸ | HPGD | P15428 | 5/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.38 |
| ▸ | LMNA | P02545 | 4/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 3/20 | 0.37 |
| ▸ | HTT | P42858 | 2/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | SRC | P12931 | 4/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | PLK1 | P53350 | 1/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4825904 | 1.00 | MEN1 (0.41) | MEN1KMT2AKDM4EALDH1A1HPGD | |
| SCHEMBL4814812 | 0.97 | ALDH1A1 (0.42) | MEN1KMT2AKDM4EALDH1A1HPGD | |
| SCHEMBL4814808 | 0.97 | ALDH1A1 (0.42) | MEN1KMT2AKDM4EALDH1A1HPGD | |
| SCHEMBL4814789 | 0.80 | CRY1 (0.34) | MEN1KMT2AKDM4EALDH1A1HPGD | |
| SCHEMBL4814796 | 0.80 | CRY1 (0.34) | MEN1KMT2AKDM4EALDH1A1HPGD | |
| SCHEMBL4814647 | 0.80 | PTGER4 (0.47) | MEN1KMT2AKDM4EALDH1A1HPGD | |
| SCHEMBL4825653 | 0.80 | KDM4E (0.39) | MEN1KMT2AKDM4EALDH1A1HPGD | |
| SCHEMBL9189270 | 0.76 | KDM4E (0.51) | MEN1KMT2AKDM4EALDH1A1HPGD | |
| SCHEMBL4821975 | 0.74 | BACE1 (0.47) | MEN1KMT2AKDM4EALDH1A1HPGD | |
| SCHEMBL14275514 | 0.74 | MEN1 (0.41) | MEN1KMT2AKDM4EALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7445877-B2 | Charge transport materials having a central disulfane linkage | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2008-11-04 | — | — | US | disclosed |
| US-7326506-B2 | Bridged charge transport materials having a central sulfur atom linkage | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2008-02-05 | — | — | US | disclosed |
| EP-1600821-B1 | Bridged charge transport materials having a central sulfur atom linkage | SAMSUNG ELECTRONICS CO LTD (KR) | 2007-02-28 | — | — | EP | disclosed |
| US-20050277038-A1 | Charge transport materials having a central disulfane linkage | S-PRINTING SOLUTION CO., LTD. (KR) | 2005-12-15 | — | — | US | disclosed |
| US-20050266329-A1 | Bridged charge transport materials having a central sulfur atom linkage | S-PRINTING SOLUTION CO., LTD. (KR) | 2005-12-01 | — | — | US | disclosed |
| EP-1600821-A1 | Bridged charge transport materials having a central sulfur atom linkage | Samsung Electronics Co., Ltd. (KR) | 2005-11-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050266329-A1 | Bridged charge transport materials having a central sulfur atom linkage | NR2E3, NR4A2, NR2C2 | MEN1 1456/4885KMT2A 2812/4885KDM4E 3516/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.